What Is a Regenerative Medicine Clinic?
Regenerative medicine clinics may offer platelet-rich plasma, prolotherapy, bone marrow aspirate concentrate, and other procedure-based services. Some businesses also market peptides, exosomes, or cell-related products, but each product category carries a different regulatory and clinical risk profile. A clinic should define its scope before it creates a menu, purchases equipment, or runs advertising.
The durable model begins with appropriate patient selection, clinician training, a documented treatment rationale, informed consent, sterile technique, follow-up, and an escalation path for complications. It should not assume that a procedure is permitted or appropriate merely because a competitor offers it.
Patients often pay directly for these services. Cash pay can simplify collection, but it does not lower the standard for records, consent, privacy, safety, or truthful marketing.
Entity Structure, CPOM, and Medical Oversight
Corporate practice of medicine rules can limit who owns a clinical entity and who controls diagnosis, treatment, protocols, referrals, and clinical staffing. In restrictive states, founders often use a physician-owned PC or PLLC for professional services and an MSO for non-clinical administration. Healthcare counsel should tailor the structure to each state served.
The medical director must have real authority. Responsibilities commonly include approving protocols, confirming clinician competency, reviewing charts and outcomes, handling adverse-event escalation, and supervising or collaborating with NPs and PAs when required. A passive signature arrangement does not create a safe governance model.
The MSO can provide technology, facilities, scheduling, marketing, and billing support. It should not force clinical eligibility, prescribe treatment volume, or interfere with a physician's independent judgment.
FDA Pathways and Product Compliance
The Section 361 HCT/P framework has narrow criteria. A product generally must meet all applicable requirements, including minimal manipulation and homologous use, to avoid being regulated as a drug, biologic, or device under a different pathway. The same surgical procedure exception is also narrow and requires fact-specific analysis.
PRP prepared and used in a defined clinical workflow is not the same regulatory question as bone marrow processing, adipose-derived products, exosomes, or donor-derived materials. Marketing terms do not determine regulatory status. Review the actual source, manipulation, processing, intended use, labeling, storage, transport, and claims.
If a product is investigational or lacks an applicable exemption or authorization, do not market it as an established treatment. Engage regulatory counsel and maintain a documented product-review file before procurement.
- ✓Create a product and procedure inventory with sourcing and intended-use details.
- ✓Analyze minimal manipulation, homologous use, and any asserted exception with qualified counsel.
- ✓Avoid claims that imply FDA approval, disease treatment, or guaranteed regeneration without support.
- ✓Re-review product status and enforcement developments on a defined cadence.
Schedule a Healthcare Strategy Session
Get StartedLicensing, Credentialing, and Clinical Readiness
Every clinician must hold active authority in the state where the patient is treated. Physicians, NPs, PAs, RNs, and technicians have different scope and supervision requirements. Build a credentialing file with licenses, training records, competency validation, exclusions screening, malpractice coverage, and protocol acknowledgment.
If the practice bills Medicare, Medicaid, or commercial plans, enrollment and credentialing require separate work. Maintain CAQH profiles where used, complete PECOS enrollment for Medicare participation, and confirm that billing providers, locations, and reassignment relationships are accurate. Cash-pay clinics still need disciplined identity, documentation, and clinical governance.
Procedure privileges, emergency readiness, referral relationships, and training for imaging guidance or sedation should be addressed before the first patient is scheduled.
| Readiness area | Operational focus |
|---|---|
| Clinician authority | State license, scope, collaboration or supervision, and procedure competency |
| Enrollment | CAQH, PECOS, Medicare, Medicaid, and payer credentialing where billing applies |
| Facility readiness | Emergency plan, infection control, supplies, and referral pathways |
| Documentation | Eligibility, rationale, consent, procedure note, follow-up, and incident reporting |
Safety, Privacy, DEA, and CLIA
A HIPAA-compliant EMR, role-based access, business associate agreements, secure messaging, privacy training, and incident response are core operational requirements. OSHA obligations include bloodborne pathogen training, exposure-control planning, sharps safety, PPE, and post-exposure processes.
DEA registration may be relevant if clinicians prescribe or administer controlled substances, including medication used around procedures. Confirm prescriber authority, storage, inventory, documentation, and state controlled-substance requirements rather than borrowing a workflow from an unrelated clinic.
CLIA issues depend on whether the clinic performs testing or operates an in-office laboratory process. Work with qualified laboratory and legal advisors to determine the appropriate certificate, waiver, or alternative workflow.
- ✓Implement HIPAA policies, BAAs, access controls, and breach-response procedures.
- ✓Maintain OSHA bloodborne pathogen, sharps, PPE, and exposure-control processes.
- ✓Assess DEA registration and controlled-substance workflows if applicable.
- ✓Obtain qualified advice on CLIA obligations before offering in-office testing or processing.
Sourcing, Labs, and Procedure Operations
Sourcing is an extension of patient safety. For PRP or BMAC workflows, define equipment validation, staff training, sterility, labeling, chain of custody, and procedure documentation. For external laboratories or biologics suppliers, verify appropriate licensing, product documentation, testing practices, storage and shipping controls, recall processes, and the ability to support a timely investigation.
Do not allow sales materials to substitute for diligence. The clinic should know what it is receiving, where it came from, how it was handled, and what the supplier represents about its regulatory status. Document the medical director's role in approving products and reviewing exceptions.
Partnership agreements should define responsibilities for results, quality complaints, patient communication, and adverse-event reporting.
Need a Medical Director?
Get StartedStartup Costs, Staffing, and Technology
A focused PRP practice may launch with a smaller equipment footprint than a full procedure center, while a BMAC, imaging-guided, or multi-service clinic can require significant capital. Budget for entity formation, legal review, medical oversight, equipment, leasehold improvements, supplies, insurance, training, EMR, cybersecurity, payroll, and working capital.
Staffing can include a physician medical director, treating physicians or advanced practitioners, RNs or medical assistants, a procedure coordinator, front desk staff, and operations support. Match staffing to patient volume and scope; avoid delegating tasks beyond state scope or competency.
Choose an EMR that supports procedure notes, consent, photo or imaging governance where used, lab interfaces, secure communications, inventory, and audit trails.
Revenue Cycle, Pricing, and Patient Acquisition
Many clinics price services from roughly $500 for selected injections to more than $5,000 for complex treatment plans. Publish what is included, what is not included, cancellation and refund terms, follow-up expectations, and any financing disclosures. If a clinic bills insurance, coding, documentation, medical necessity, prior authorization, and payer rules require dedicated revenue-cycle controls.
Marketing should educate rather than promise. FTC and FDA scrutiny can arise from unsubstantiated claims about curing disease, avoiding surgery, regenerating tissue, or delivering permanent outcomes. Review websites, social content, seminar decks, testimonials, influencer agreements, and lead scripts.
Track acquisition cost, consult-to-treatment conversion, follow-up completion, outcomes reporting, adverse events, and refund trends. Metrics should guide operations without pressuring clinicians to recommend procedures.
- ✓Use written financial consent and transparent packages for cash-pay services.
- ✓Maintain coding and documentation controls if submitting claims.
- ✓Review all health claims, testimonials, and before-and-after content before publication.
- ✓Keep clinical eligibility separate from sales incentives and conversion goals.
Compliance and Risk Management
Informed consent should address the individual procedure, material risks, alternatives, expected follow-up, uncertainty, and when to seek urgent care. For experimental, investigational, or off-label discussions, the record should accurately describe the status and avoid language that minimizes uncertainty. Consent cannot replace a sound clinical rationale.
Professional liability coverage should be reviewed specifically for the procedures, products, and states involved. Confirm exclusions, prior-acts coverage, policy limits, reporting duties, and whether the carrier understands the clinic's service mix.
Conduct recurring chart, product, marketing, privacy, safety, and incident audits. Give the medical director authority to pause unsafe care, revise protocols, retrain staff, and document corrective action.
- ✓Use procedure-specific informed consent reviewed by qualified counsel and clinicians.
- ✓Confirm malpractice coverage matches the actual service and product scope.
- ✓Audit charts, sourcing records, consent, marketing, and adverse-event logs regularly.
- ✓Document incident review, corrective action, retraining, and protocol updates.